Cerus signs purchase agreement for deployment of INTERCEPT Blood System Cerus announced that it has signed a two-year purchase agreement with two regional Swiss Red Cross Blood Services for deployment of the INTERCEPT Blood System for plasma in Lausanne and Zurich. These two pilot centers supply an estimated 15,000 plasma units annually. The INTERCEPT platelet system is currently used by all 13 Swiss Red Cross blood centers. Switzerland produces approximately 35,000 platelet units and 50,000 plasma units for transfusion annually.
News For CERS From The Last 14 Days
Check below for free stories on CERS the last two weeks.